Advanced QbD-Based Process Optimization of Clopidogrel Tablets with Insights into Industrial Manufacturing Design
Open Access
- 17 May 2025
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 17 (5) , 659
Abstract
Background/Objectives: Traditional Quality by Testing (QbT) strategies rely heavily on end-product testing and offer limited insight into how critical process parameters (CPPs) influence product quality. This increases the risk of variability and inconsistent outcomes. To overcome these limitations, this study aimed to implement a Quality by Design (QbD) approach to optimize the manufacturing process of clopidogrel tablets. Methods: A science- and risk-based QbD framework was applied to identify and prioritize key CPPs, intermediate critical quality attributes (iCQAs), and final product CQAs across key unit operations—pre-blending, dry granulation, post-blending, lubrication, and compression. Risk assessment tools and statistical design of experiments (DoE) were used to define proven acceptable ranges (PARs). Results: The study revealed strong correlations between CPPs and CQAs, allowing the definition of PARs and development of a robust control strategy. This led to improved manufacturing consistency, reduced variability, and enhanced process understanding. Conclusions: The QbD approach minimized reliance on end-product testing while ensuring high-quality outcomes. This study offers a novel QbD implementation tailored to the manufacturing challenges of clopidogrel tablets, providing a validated approach that integrates dry granulation CPPs with process-specific CQAs. These results demonstrate the value of QbD in achieving robust pharmaceutical manufacturing and meeting regulatory expectations.Keywords
Funding Information
- National Research Foundation of South Korea (NRF) (RS-2024-00407053)
This publication has 53 references indexed in Scilit:
- Application of quality by design in optimization of nanoformulations: Principle, perspectives and practicesDrug Delivery and Translational Research, 2024
- Self-amplifying mRNA vaccines: Mode of action, design, development and optimizationDrug Discovery Today, 2022
- Quality by design (QbD) approach in marketing authorization procedures of Non-Biological Complex Drugs: A critical evaluationEuropean Journal of Pharmaceutics and Biopharmaceutics, 2022
- Impact of Surfactants on the Performance of Clopidogrel-Copovidone Amorphous Solid Dispersions: Increased Drug Loading and Stabilization of NanodropletsPharmaceutical Research, 2022
- Implementation of Quality by Design (QbD) Principles in Regulatory Dossiers of Medicinal Products in the European Union (EU) Between 2014 and 2019Therapeutic Innovation & Regulatory Science, 2021
- Trends-process analytical technology in solid oral dosage manufacturingEuropean Journal of Pharmaceutics and Biopharmaceutics, 2020
- Quality by design in pharmaceutical manufacturing: A systematic review of current status, challenges and future perspectivesEuropean Journal of Pharmaceutics and Biopharmaceutics, 2020
- Systematic evaluation of common lubricants for optimal use in tablet formulationEuropean Journal of Pharmaceutical Sciences, 2018
- Validation and applications of an expedited tablet friability methodInternational Journal of Pharmaceutics, 2015
- The effect of mixer properties and fill level on granular flow in a bladed mixerAIChE Journal, 2009